PF-07923567

N/A

Report date: 2023/08/17 17:51:49
NME

Base Information

Drug NamePF-07923567
Drug Alias NamePF-07923567RV-299
ClassificationOther
Mechanisms of ActionNucleocapsid proteins inhibitors
TargetsNucleocapsid proteins
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesReviral Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncReviral Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A